Sanofi

News

Sanofi may airlift medicines into UK after Brexit

France’s Sanofi has said it may fly supplies of flu vaccine into the UK if Brexit causes travel disruption after the country leaves the EU.

News

FDA unconvinced by Sanofi’s Zynquista in type 1 diabetes

Sanofi’s hopes of getting its dual SGLT inhibitor sotagliflozin approved alongside insulin for type 1 diabetes in the US have been dashed by the FDA.

Digital

EyeForPharma Barcelona 2019 Feature Banner Round-Up

Eyeforpharma Barcelona 2019 roundup

This year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting the downfall of pharma as we know it – but there were plenty of speake

News

Praluent approved to reduce CV risk in Europe

The European Commission has approved Sanofi and Regeneron’s Praluent for reducing cardiovascular risk in adults with established atherosclerotic CV disease (ASCVD), giving the drug another advan

News

CHMP okays Sanofi’s Zynquista in type 1 diabetes

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).

News

Sanofi/Regeneron’s Dupixent shows more promise in nasal poly...

Sanofi and Regeneron’s attempts to make Dupixent into a blockbuster franchise have been boosted with more strong phase 3 results in patients with chronic rhinosinusitis with nasal polyps (CRSwNP

Sanofi may airlift medicines into UK after Brexit

FDA unconvinced by Sanofi’s Zynquista in type 1 diabetes

Eyeforpharma Barcelona 2019 roundup

Praluent approved to reduce CV risk in Europe

CHMP okays Sanofi’s Zynquista in type 1 diabetes

Sanofi/Regeneron’s Dupixent shows more promise in nasal poly...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Sanofi

Editor's Picks